| INVESTMENT OBJECTIVE | ![]() |
| INVESTMENT DISCIPLINE | |
| Performance (As of 12/31/2009) |
| Performance Chart |
![]() |
| YTD | 1-YEAR | 3-YEAR | 5-YEAR | 10-YEAR | SINCE INCEPTION | |
| 44.44 | 44.44 | -0.43 | 4.62 | -4.94 | 8.55 | |
| 37.38 | 37.38 | -1.83 | 3.27 | 6.36 | 10.66 | |
| 43.51 | 43.51 | -2.55 | 1.99 | 0.16 | N/A |
| PAST PERFORMANCE DOES NOT GUARANTEE FUTURE RESULTS. THE INVESTMENT RETURN AND PRINCIPAL VALUE OF AN INVESTMENT WILL FLUCTUATE SO THAT AN INVESTOR'S UNITS, WHEN REDEEMED, MAY BE WORTH MORE OR LESS THAN THEIR ORIGINAL COST. CURRENT PERFORMANCE MAY BE LOWER OR HIGHER THAN THE PAST PERFORMANCE DATA QUOTED. PERFORMANCE INFORMATION AS OF THE MOST RECENT MONTH-END IS AVAILABLE AT WWW.PRUDENTIAL.COM. Returns shown for Service Shares for periods prior to their inception (December 31, 1999) are derived from the historical performance of the Institutional shares (Inception date - September 13, 1993), adjusted to reflect the higher operating expenses of Service Shares.The rates of return reflect the reinvestment of all dividends and capital gains, and the deduction of investment management fees and expenses. They do not reflect charges specific to your contract such as cost of insurance, mortality and expense risk charges, riders and sales charges. If they did, the performance quoted would be significantly lower. For the specific charges and expenses associated with your product, please refer to the prospectus. Returns of less than one year are not annualized. For variable life insurance products, refer to the hypothetical illustrations in the prospectus, which show the effect on performance of various assumptions regarding the cost of insurance protection. You may also obtain a personalized illustration of historical performance, which reflects the cost of your policy's insurance protection. |
| back to top |
| Fund Facts & Holdings (As of 12/31/2009 unless noted otherwise) |
| Portfolio Data2 |
| Inception Date-Service Shares : 12/31/1999 Number of Holdings : 85 Net Assets : $593.9 Million |
| Largest Stock Holdings (% of Assets)2 | |
| Crown Castle International | 4.0% |
| Celgene | 3.2 |
| Amphenol | 2.4 |
| ATMEL | 2.2 |
| Li & Fung, Ltd. | 2.1 |
| Covidien Ltd. | 2.0 |
| St Jude Medical Inc | 2.0 |
| Kla-Tencor | 2.0 |
| Amdocs, Ltd. | 1.9 |
| MSC Industrial Direct | 1.9 |
| Industry Breakdown (% of Assets)2 | |
| Medical - Biomedical and Genetic | 6.5% |
| Medical Products | 4.7 |
| Technology Services | 4.4 |
| Wireless Equipment | 4.0 |
| Distribution/Wholesale | 3.2 |
| Oil & Gas - Exploration & Production | 3.1 |
| Medical Instruments | 2.7 |
| Containers - Metal and Glass | 2.6 |
| Electronic Connectors | 2.4 |
| Commercial Services - Financial | 2.3 |
| PORTFOLIO MANAGEMENT |
Brian Demain, CFA is Portfolio Manager of the Mid Cap Growth portfolios and is Portfolio Manager and Executive Vice President of Janus Enterprise Fund and Janus Aspen Enterprise Portfolio. Mr. Demain joined Janus in July 1999 as an equity research analyst. From July 1999 to October 2007, Mr. Demain served as an equity research analyst, focusing on companies in the media and communications sectors. He received his bachelor of arts degree in economics from Princeton University, where he graduated Summa Cum Laude and Phi Beta Kappa. Mr. Demain's academic achievements culminated with his winning of a Senior Thesis Prize. Mr. Demain holds the Chartered Financial Analyst designation and has 10 years of professional investment experience. |
| FIRM OVERVIEW |
![]() |
Investors should consider the contract and the underlying portfolios' investment objectives, risks, and charges and expenses carefully before investing. The contract's prospectus and the underlying portfolios' prospectus contain this and other important information. Read them carefully before investing or sending money. |
| back to top |